Bureau Veritas Acquires ArcVera Renewables to Accelerate Growth and Create a New Stronghold in the Renewables Sector in North America
Bureau Veritas, a global leader in Testing, Inspection, and Certification services, today announced the acquisition of ArcVera Renewables, a specialized provider in finance-grade consulting and technical services for wind, solar, and battery storage projects worldwide. This acquisition is aligned with Bureau Veritas LEAP | 28 strategy to create a new stronghold in the fast-growing sector of renewables.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240903622866/en/
Hinda Gharbi, CEO Bureau Veritas (Photo: Business Wire)
Bureau Veritas contributes to the energy transition by providing the power sector customers end-to-end solutions to meet the immediate and future challenges of developing and operating renewable assets. This acquisition will expand Bureau Veritas’s capabilities, primarily in North America, to support landowners, developers and owners, and investors in delivering their wind and solar farm projects.
ArcVera Renewables provides customers with advanced technical site and resources assessments, and consultancy during the development and operations stages of utility-scale renewables projects. The company’s engineers, technical and subject matter experts support clients with risk reduction and ensure optimal asset performance. Since its inception, ArcVera Renewables has supported 9GW of solar projects in North and South America and has evaluated projects now representing 93,000 MW of wind capacity in the United States. ArcVera Renewables delivered revenues of €6.5 million in 2023 and is headquartered in Golden, Colorado.
“The acquisition of ArcVera Renewables supports our LEAP | 28 strategy, aimed at expanding our services and strengthening our position as a leader in the renewables and power generation sector,”said Hinda Gharbi, Chief Executive Officer of Bureau Veritas. “ArcVera Renewables has built a reputation for excellence in due diligence and operational verification on renewable projects. Their expertise will be a valuable addition to Bureau Veritas’s portfolio of capabilities for the energy transition services. I warmly welcome all new colleagues from ArcVera Renewables to Bureau Veritas.”
“We saw how the broad and deep technical prowess of Bureau Veritas would be a powerful catalyst for ArcVera Renewables”added Greg Poulos, CEO of ArcVera Renewables. “Since inception, our goal has been to accelerate the clean transformation of the world’s energy sector by delivering trustworthy, valuable, detailed, and independent technical analysis for the success of our clients. Joining Bureau Veritas is a leap forward in achieving this goal and is likewise transformational for the ArcVera team and its growing global renewable energy client-base.”
***
About Bureau Veritas
Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress.
With a vision to be the preferred partner for its customers’ excellence and sustainability, the company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 83,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.
Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40 ESG, CAC Next 20, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com, and follow us on LinkedIn.
About ArcVera Renewables
ArcVera Renewables provides finance-grade consulting and technical services for wind, solar and storage projects worldwide. For the last four decades, ArcVera Renewables has been dedicated to delivering next-generation innovation in renewable energy to meet the needs of landowners, project developers, investors, project owners and operators globally. ArcVera Renewables provides technically sound and accuracy-driven technical services, including prospecting and resource assessment, independent technical and financial engineering, as well as plant optimization, operations and repowering. Subsidiary offices are located in India, Brazil, and South Africa, serving all continents.
For more information, visit www.arcvera.com, and follow us on LinkedIn.
Our information is certified with blockchain technology.
Check that this press release is genuine at www.wiztrust.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903622866/en/
Contacts
ANALYST/INVESTOR CONTACTS
Laurent Brunelle
+33 (0)1 55 24 76 09
laurent.brunelle@bureauveritas.com
Colin Verbrugghe
+33 (0)1 55 24 77 80
colin.verbrugghe@bureauveritas.com
Karine Ansart
+33 (0)1 55 24 76 19
karine.ansart@bureauveritas.com
MEDIA CONTACTS
Anette Rey
+33 (0)6 69 79 84 88
anette.rey@bureauveritas.com
Martin Bovo
+33 (0) 6 14 46 79 94
martin.bovo@bureauveritas.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair12.9.2024 01:05:00 EEST | Press release
Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerve injury requiring repair. This designation follows the results from the Phase 2 NEUROFUSE study and several interactions with the FDA. NTX-001 has the potential to be a groundbreaking therapy in the field of nerve repair. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911372663/en/ Evan L. Tzanis, Chief Operating Officer and EVP of R&D, Neuraptive Therapeutics, Inc. (Photo: Business Wire) Neuraptive is preparing to launch a Phase 3 pivotal program for NTX-001 in early 2025. The program will consist of a single randomized, double-blind, placebo-controlled study assessing the efficacy and safety of NTX-001 in patients with peripheral nerve injury requiring repair. The final protocol for this single Phase 3 study is currently b
Mouser Electronics Explores Sustainable Smart Grid Innovation in Latest Content Series11.9.2024 18:41:00 EEST | Press release
Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today released the latest installment of its Empowering Innovation Together (EIT) technology series, which explores the benefits of incorporating renewable energy into smart grid technology, emphasizing the role of AI and 5G in achieving sustainable grid management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911011855/en/ In the latest installment of its Empowering Innovation Together (EIT) technology series, Mouser explores the benefits of incorporating renewable energy into smart grid technology, emphasizing the role of AI and 5G in achieving sustainable grid management. (Photo: Business Wire) Adopting a smart grid system enhances the precision of power usage monitoring and energy distribution and enables two-way communication between the system and users. This decentralized approach
Delinea Named a Leader in 2024 Gartner ® Magic Quadrant™ for Privileged Access Management11.9.2024 18:30:00 EEST | Press release
Delinea, a pioneering provider of solutions for securing identities through centralized authorization, today announced its recognition as a Leader in the 2024 Gartner Magic Quadrant for Privileged Access Management (PAM). This marks the 6th consecutive time that Delinea has been acknowledged in the Leaders Quadrant; Delinea stated that, in their opinion, this highlights the company's ongoing commitment to delivering market-trusted security solutions. “We are honored to be recognized once again as a Leader by Gartner,” said Art Gilliland, CEO of Delinea. “Identity security serves as the first line of defense, as every identity, both human and non-human, and the data with which they interact are targets in today’s modern enterprises. I believe this acknowledgement reaffirms our commitment to safeguarding our clients while delivering solutions that not only enhance security but also remove complexity, elevating the user experience.” As Gartner states, “growth continues to be driven by the
CyberArk Named a Leader in the 2024 Gartner® Magic Quadrant™ for Privileged Access Management11.9.2024 18:04:00 EEST | Press release
CyberArk (NASDAQ: CYBR), the identity security company, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Privileged Access Management.1 CyberArk is positioned as a Leader for the sixth consecutive time and is positioned furthest in Completeness of Vision, which evaluates vendors on offering (product) strategy, innovation and market understanding among other evaluation criteria. With 93% of organizations suffering two or more identity-related breaches in the last 12 months, managing and securing identities has become a critical requirement. The CyberArk Identity Security Platform enables organizations to secure the entire spectrum of identities, including workforce, IT, developer and machine, supporting modern access use cases such as the need to enforce Zero Standing Privileges in public cloud environments. A core component of the platform is CyberArk’s privileged access management (PAM) capabilities, which allow customers to apply flexible privilege
Spencer Health Solutions Achieves ISO 27001 Certification11.9.2024 16:55:00 EEST | Press release
Spencer Health Solutions (SHS), a healthcare technology leader in smart medication management, announced that it has achieved ISO 27001:2022 certification. This prestigious accreditation underscores the company's unwavering commitment to safeguarding patient data and ensuring the highest standards of information security. ISO 27001 is a globally recognized information security management system (ISMS) standard that ensures organizations implement robust measures to protect their assets from threats. By achieving this certification, Spencer Health Solutions has demonstrated its dedication to: Confidentiality: Protecting patient data from unauthorized disclosure. Integrity: Ensuring the accuracy and completeness of medication dispensing records. Availability: Guaranteeing timely access to medication dispensing information when needed. “We are proud to announce that Spencer Health Solutions has achieved ISO 27001 certification,” said Tom Rhoads, CEO of Spencer Health Solutions. “This acco
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom